Cabergoline - Open Access .click

Results 101 to 110 of about 3,840 (115)

Some of the next articles are maybe not open access.

Treatment of Macroprolactinoma With Cabergoline

The Journal of Urology, 1997
OBJECTIVE Cabergoline is now established as an effective and well‐tolerated treatment for prolactinoma. However, there are relatively few published data on the treatment of macro‐, as opposed to micro‐, prolactinoma. We have therefore reviewed the efficacy and safety of cabergoline in the treatment of patients with prolactin‐secreting macroadenomas ...
Ferrari, C.I. +10 more
openaire +4 more sources

Pituitary apoplexy associated with cabergoline therapy

Journal of Clinical Neuroscience, 2013
Pituitary apoplexy is a rare medical emergency which results from hemorrhage or infarction in the pituitary gland. One of the predisposing factors is treatment with dopamine agonists, especially bromocriptine. We report a 20-year-old Chinese man with prolactinoma who developed pituitary apoplexy 6 weeks after initiation of cabergoline.
Edwin Chng, Rinkoo Dalan
openaire +3 more sources

Cabergoline for preventing ovarian hyperstimulation syndrome

2010
Ovarian hyperstimulation syndrome (OHSS) is a complication resulting from administration of human chorionic gonadotrophin (hCG) in assisted reproduction technology (ART) treatment. Most case are mild, but forms of moderate or severe OHSS appear in 3% to 8% of in vitro fertilisation (IVF) cycles.
Roger Hart +5 more
openaire +3 more sources

Cabergolin versus Pergolid